The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Abstract
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a paucity of adipose (fat) tissue which is evident at birth and is accompanied by a severe resistance to insulin, leading to hyperinsulinaemia, hyperglycaemia and enlarged fatty liver. We have developed a mouse model that mimics these features of CGL: the syndrome occurs in transgenic mice expressing a truncated version of a nuclear protein known as nSREBP-1c (for sterol-regulatory-element-binding protein-1c) under the control of the adipose-specific aP2 enhancer. Adipose tissue from these mice was markedly deficient in messenger RNAs encoding several fat-specific proteins, including leptin, a fat-derived hormone that regulates food intake and energy metabolism. Here we show that insulin resistance in our lipodystrophic mice can be overcome by a continuous systemic infusion of low doses of recombinant leptin, an effect that is not mimicked by chronic food restriction. Our results support the idea that leptin modulates insulin sensitivity and glucose disposal independently of its effect on food intake, and that leptin deficiency accounts for the insulin resistance found in CGL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Shimomura et al. have demonstrated that leptin treatment reversed insulin resistance in a fat-specific aP2-SREBP-1c knockout mouse model of congenital generalized lipodystrophy (4).”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [4]
In the citing paper
“Taken together, these data suggest that intrahepatic and intramyocellular lipid lowering effects of leptin were mediated mostly by a reduction in energy intake, as opposed to a leptininduced increase in energy expenditure, although a lipolytic effect of leptin on these tissues cannot be ruled out (4, 28).”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [4]
In the citing paper
“Several lines of evidence from both humans and rodent models suggest that leptin deficiency contributes to insulin resistance and diabetes in this setting (139, 168, 169).”
From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [168]
In the citing paper
“the diabetes phenotype of these lipodystrophic mice is also ameliorated by leptin administration via a mechanism that is, at least in part, independent of its effect on food intake and body weight (64, 168).”
From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [168]
In the citing paper
“First in rodent models (5) and then in preliminary short-term studies in humans (6), it was shown that recombinant leptin administration could ameliorate dyslipidemia, insulin resistance, and diabetes.”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [5]
In the citing paper
“Moreover, leptin dramatically improves insulin sensitivity in human lipodystrophy and in lipodystrophic mouse models which are characterized by low serum leptin levels and by severe insulin resistance (Oral et al., 2002; Petersen et al., 2002; Shimomura et al., 1999).”
From Leptin-Dependent Control of Glucose Balance and Locomotor Activity by POMC Neurons (2009) · cites this paper as Shimomura et al., 1999
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citationADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.Preprint
Kim, J. B., & Spiegelman, B. M. (1996) · Genes & Development · doi:10.1101/gad.10.9.1096 · Cited by 1,026
Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790
Self-citationLife without white fat: a transgenic mousePreprint
Moitra, J., Mason, M. M., Olive, M., Krylov, D. Y., Gavrilova, O., Marcus‐Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.20.3168 · Cited by 776
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
McGarry, J. D. (1992) · Science · doi:10.1126/science.1439783 · Cited by 657
Tontonoz, P., Kim, J. B., Graves, R. A., & Spiegelman, B. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4753-4759.1993 · Cited by 599
Regulation of fatty acid homeostasis in cells: Novel role of leptin
Unger, R. H., Zhou, Y.-T., & Orci, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2327 · Cited by 435
Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y., & Horton, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35299 · Cited by 333
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 997
Mauvais-Jarvis, F., Ueki, K., Fruman, D. A., Hirshman, M. F., Sakamoto, K., Goodyear, L. J., Iannacone, M., Accili, D., Cantley, L. C., & Kahn, C. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213305 · Cited by 207
Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells
Shojima, N., Sakoda, H., Ogihara, T., Fujishiro, M., Katagiri, H., Anai, M., Onishi, Y., Ono, H., Inukai, K., Abe, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1737 · Cited by 207
The Physiology of Cellular Liporegulation
Unger, R. H. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142622 · Cited by 208
Genetic Modulation of PPARγ Phosphorylation Regulates Insulin Sensitivity
Rangwala, S. M., Rhoades, B., Shapiro, J. S., Rich, A. S., Kim, J. K., Shulman, G. I., Kaestner, K. H., & Lazar, M. A. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00274-0 · Cited by 204
Reitman, M. L., Arioglu, E., Gavrilova, O., & Taylor, S. I. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00309-x · Cited by 193
Chou, C. J., Haluzı́k, M., Gregory, C., Dietz, K. R., Vinson, C., Gavrilova, O., & Reitman, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202449200 · Cited by 197
Anti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
Medina‐Gómez, G., Gray, S. L., & Vidal‐Puig, A. (2007) · Public Health Nutrition · doi:10.1017/s1368980007000614 · Cited by 204
Resistin- and Obesity-associated Metabolic Diseases
Lazar, M. A. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-985897 · Cited by 201
FAT CELLS: Afferent and Efferent Messages Define New Approaches to Treat Obesity
Lafontan, M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095843 · Cited by 191
Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine
Unger, R. H. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.014 · Cited by 184
Valsamakis, G., McTernan, P. G., Chetty, R., Al‐Daghri, N. M., Field, A., Hanif, W., Barnett, A. H., & Kumar, S. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.022 · Cited by 189
Hypothalamic Responses to Long-chain Fatty Acids Are Nutritionally Regulated
Morgan, K., Obici, S., & Rossetti, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400458200 · Cited by 192
Sutinen, J., Häkkinen, A.-M., Westerbacka, J., Seppälä-Lindroos, A., Vehkavaara, S., Halavaara, J., Järvinen, A., Ristola, M., & Yki-Järvinen, H. (2002) · AIDS · doi:10.1097/00002030-200211080-00011 · Cited by 184
Lipid droplet proteins and metabolic diseases
Xu, S., Zhang, X., & Liu, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.019 · Cited by 192
Peripheral metabolic actions of leptin
Muoio, D. M., & Lynis Dohm, G. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0223 · Cited by 183
Koutníková, H., Cock, T., 渡辺, 光., Houten, S. M., Champy, M., Dierich, A., & Auwerx, J. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336090100 · Cited by 184
Diker‐Cohen, T., Cochran, E. K., Görden, P., & Brown, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4491 · Cited by 181
Reue, K., Xu, P., Wang, X.-P., & Slavin, B. G. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32011-3 · Cited by 177
Lee, M.-W., Lee, M., & Oh, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060854 · Cited by 192
Efficacy of leptin therapy in the different forms of human lipodystrophy
Chong, A. Y., Lupsa, B. C., Cochran, E. K., & Görden, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1502-9 · Cited by 175
Poirier, H., Shapiro, J. S., Kim, R. J., & Lazar, M. A. (2006) · Diabetes · doi:10.2337/db06-0036 · Cited by 188
Villanueva, C. J., Monetti, M., Shih, M., Zhou, P., Watkins, S. M., Bhanot, S., & Farese, R. V. (2009) · Hepatology · doi:10.1002/hep.22980 · Cited by 180
Animal models of steatohepatitis
Koteish, A. A., & Diehl, A. M. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0332 · Cited by 175
Bates, S. H., Kulkarni, R. N., Seifert, M., & Myers, M. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.02.001 · Cited by 173
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
Willebrords, J., Pereira, I. V. A., Maes, M., Yanguas, S. C., Colle, I. O., Bossche, B. V. D., da Silva, T. C., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A. F., et al. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.05.002 · Cited by 177
Jan, V., Cervera, P., Maachi, M., Baudrimont, M., Kim, M. J., Vidal, H., Girard, P., Levan, P., Rozenbaum, W., Lombès, A., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900412 · Cited by 169
Maintaining cholesterol homeostasis: Sterol regulatory element-binding proteins
Weber, L. W. D. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i21.3081 · Cited by 172
Carr, A. D., Hudson, J., Chuah, J., Mallal, S. A., Law, M. G., Hoy, J., Doong, N., French, M. A., Smith, D., & Cooper, D. A. (2001) · AIDS · doi:10.1097/00002030-200109280-00010 · Cited by 172
Antiobesity Effects of yerba maté Extract (Ilex paraguariensis) in High‐fat Diet–induced Obese Mice
Arçari, D. P., Bartchewsky, W., dos Santos, T. W., Oliveira, K. A., Funck, A., Pedrazzoli, J., de Souza, M. F. F., Saad, M. J. A., Bastos, D. H. M., Gambero, A., et al. (2009) · Obesity · doi:10.1038/oby.2009.158 · Cited by 175
Leptin therapy, insulin sensitivity, and glucose homeostasis
Paz-Filho, G., Mastronardi, C. A., Wong, M., & Licinio, J. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.105571 · Cited by 173
Inoue, M., Maehata, E., Yano, M., Taniyama, M., & Suzuki, S. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.006 · Cited by 168
Decreased Expression of Adipogenic Genes in Obese Subjects with Type 2 Diabetes
Dubois, S. G., Heilbronn, L. K., Smith, S. R., Albu, J., Kelley, D. E., & Ravussin, É. (2006) · Obesity · doi:10.1038/oby.2006.178 · Cited by 170
Lee, J. H., Chan, J. L., Sourlas, E., Raptopoulos, V., & Mantzoros, C. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1545 · Cited by 163
Leptin and the Control of Metabolism: Role for Stearoyl-CoA Desaturase-1 (SCD-1)
Cohen, P., & Friedman, J. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.9.2455s · Cited by 165
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170042 · Cited by 197
German, J., Kim, F., Schwartz, G. J., Havel, P. J., Rhodes, C. J., Schwartz, M. W., & Morton, G. J. (2009) · Endocrinology · doi:10.1210/en.2009-0445 · Cited by 164
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 154
Leshan, R. L., Louis, G. W., Jo, Y., Rhodes, C. J., Münzberg, H., & Myers, M. G. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0155-09.2009 · Cited by 162
Muscular diacylglycerol metabolism and insulin resistance
Timmers, S., Schrauwen, P., & den Bosch, J. D. V. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.002 · Cited by 163
Leptin and the Regulation of Body Weigh
Friedman, J. M. (2011) · The Keio Journal of Medicine · doi:10.2302/kjm.60.1 · Cited by 169
The role of leptin in health and disease
Ramos-Lobo, A. M., & Donato, J. (2017) · Temperature · doi:10.1080/23328940.2017.1327003 · Cited by 172
Inflammation and adipose tissue macrophages in lipodystrophic mice
Herrero, L., Shapiro, H., Nayer, A., Lee, J., & Shoelson, S. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905310107 · Cited by 163
Transgenic Approach to the Study of Body Weight Regulation
Inui, A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01435-2 · Cited by 159
Leptin and its metabolic interactions – an update
Anubhuti, A., & Arora, S. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00852.x · Cited by 157
Central nervous system regulation of organismal energy and glucose homeostasis
Myers, M. G., Affinati, A. H., Richardson, N. E., & Schwartz, M. W. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00408-5 · Cited by 165
Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function
Boucher, J., Softic, S., El Ouaamari, A., Krumpoch, M. T., Kleinridders, A., Kulkarni, R. N., O’Neill, B. T., & Kahn, C. R. (2016) · Diabetes · doi:10.2337/db16-0212 · Cited by 154
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
Jelenik, T., Kaul, K., Séquaris, G., Flögel, U., Phielix, E., Kotzka, J., Knebel, B., Fahlbusch, P., Hörbelt, T., Lehr, S., et al. (2017) · Diabetes · doi:10.2337/db16-1147 · Cited by 154
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 155
Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats
Levy, J. R., Clore, J. N., & Stevens, W. D. (2004) · Hepatology · doi:10.1002/hep.20093 · Cited by 156
Central Leptin Acutely Reverses Diet-Induced Hepatic Insulin Resistance
Pocai, A., Morgan, K., Buettner, C., Gutierrez-Juarez, R., Obici, S., & Rossetti, L. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3182 · Cited by 153
Proteomic Analysis of Primary Cultures of Human Adipose-derived Stem Cells
DeLany, J. P., Floyd, Z. E., Zvonic, S., Smith, A., Gravois, A., Reiners, E., Wu, X., Kilroy, G. E., LeFevre, M. L., & Gimble, J. M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400198-mcp200 · Cited by 153
Premature Atherosclerosis Associated With Monogenic Insulin Resistance
Hegele, R. A. (2001) · Circulation · doi:10.1161/01.cir.103.18.2225 · Cited by 151
Role of leptin in the pancreatic β-cell: effects and signaling pathways
Marroquí, L., González, A., Ñeco, P., Caballero‐Garrido, E., Vieira, E. C., Ripoll, C., Nadal, Á., & Quesada, I. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0025 · Cited by 168
Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 152
Adiponectin in Anorexia Nervosa and Bulimia Nervosa
Tagami, T., Satoh, N., Usui, T., Yamada, K., Shimatsu, A., & Kuzuya, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031260 · Cited by 154
The role of leptin in glucose homeostasis
Denroche, H. C., Huynh, F. K., & Kieffer, T. J. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00203.x · Cited by 153
Does Leptin Play A Role in The Pathogenesis of Human Nonalcoholic Steatohepatitis?
Chalasani, N., Crabb, D. W., Cummings, O. W., Kwo, P. Y., Asghar, A., Pandya, P., & Considine, R. V. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08767.x · Cited by 148
Colombo, C., Cutson, J. J., Yamauchi, T., Vinson, C., Kadowaki, T., Gavrilova, O., & Reitman, M. L. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2727 · Cited by 147
Villanueva, C. J., Vergnes, L., Wang, J., Drew, B. G., Hong, C., Tu, Y., Hu, Y., Xu, P., Xu, F., Sáez, E., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.016 · Cited by 152
Neuroinflammatory basis of metabolic syndrome
Purkayastha, S., & Cai, D. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.09.005 · Cited by 150
Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy
Chan, J. L., Lutz, K., Cochran, E. K., Huang, W., Peters, Y., Weyer, C., & Görden, P. (2011) · Endocrine Practice · doi:10.4158/ep11229.or · Cited by 147
Endocrine role of bone in the regulation of energy metabolism
Zhou, R., Guo, Q., Xiao, Y., Guo, Q., Huang, Y., Li, C., & Luo, X. (2021) · Bone Research · doi:10.1038/s41413-021-00142-4 · Cited by 157
FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
Véniant, M. M., Hale, C., Helmering, J., Chen, M. M., Stanislaus, S., Busby, J., Vonderfecht, S., Xu, J., & Lloyd, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040164 · Cited by 141
Bruun, J. M., Pedersen, S. B., Kristensen, K., & Richelsen, B. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00007-2 · Cited by 143
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
Oike, Y., Akao, M., Kubota, Y., & Suda, T. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.08.002 · Cited by 140
Carvalho, E., Jansson, P., Nagaev, I., Wenthzel, A., & Smith, U. (2001) · The FASEB Journal · doi:10.1096/fsb2fj000435fje · Cited by 157
Adipose tissue as an endocrine organ: impact on insulin resistance.
Im, J., Pijl, H., & Ae, M. (2003) · PubMed · Cited by 137
There and Back Again: Leptin Actions in White Adipose Tissue
Martínez‐Sánchez, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176039 · Cited by 142
Chen, H. C., Smith, S. J., Tow, B., Elias, P. M., & Farese, R. V. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13880 · Cited by 135
Ion channels and ion selectivity
Roux, B. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160074 · Cited by 135
Leptin reduces Alzheimer’s disease-related tau phosphorylation in neuronal cells
Greco, S. J., Sarkar, S., Johnston, J. M., Zhu, X., Su, B., Casadesús, G., Ashford, J. W., Smith, M. A., & Tezapsidis, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.026 · Cited by 134
The metabolic abnormalities associated with non-alcoholic fatty liver disease
Haque, M., & Sanyal, A. J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0325 · Cited by 136
Inoue, M., Yano, M., Yamakado, M., Maehata, E., & Suzuki, S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.010 · Cited by 133
Effects of HIV protease inhibitor therapy on lipid metabolism
Hui, D. Y. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00046-2 · Cited by 135
Couturier, C., & Jockers, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302002200 · Cited by 132
Chen, H. C., Stone, S. J., Zhou, P., Buhman, K. K., & Farese, R. V. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3189 · Cited by 134
Ballantyne, G. H., Gumbs, A. A., & Modlin, I. M. (2005) · Obesity Surgery · doi:10.1381/0960892053923789 · Cited by 131
Lipoatrophic diabetes in Irs1−/−/Irs3−/− double knockout micePreprint
Laustsen, P. G., Michael, M. D., Crute, B. E., Cohen, S. E., Ueki, K., Kulkarni, R. N., Keller, S. R., Lienhard, G. E., & Kahn, C. R. (2002) · Genes & Development · doi:10.1101/gad.1034802 · Cited by 137
Effects of leptin and adiponectin on pancreatic β-cell function
Lee, Y., Magkos, F., Mantzoros, C. S., & Kang, E. S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.008 · Cited by 136
Leptin Engages a Hypothalamic Neurocircuitry to Permit Survival in the Absence of Insulin
Fujikawa, T., Berglund, E. D., Patel, V. R., Ramadori, G., Vianna, C. R., Vong, L., Thorel, F., Chera, S., Herrera, P. L., Lowell, B. B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.004 · Cited by 135
Structure and physiological functions of the human peroxisome proliferator-activated receptor γ
Zieleniak, A., Wójcik, M., & Woźniak, L. A. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0037-y · Cited by 136
Shimano, H. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)65064-2 · Cited by 128
Friedman, J. M. (2002) · Nature · doi:10.1038/415268a · Cited by 127
Leow, M. K., Addy, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021704 · Cited by 129
Mulligan, K., Khatami, H., Schwarz, J.-M., Sakkas, G. K., DePaoli, A. M., Tai, V. W., Wen, M. J., Lee, G. A., Grunfeld, C., & Schambelan, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1588 · Cited by 127
The adipocyte–myocyte axis in insulin resistance
Sell, H., Dietze‐Schroeder, D., & Eckel, J. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.10.010 · Cited by 131
Leptin: A Novel Therapeutic Strategy for Alzheimer's Disease
Tezapsidis, N., Johnston, J. M., Smith, M. A., Ashford, J. W., Casadesús, G., Robakis, N. K. R. K., Wolozin, B. L., Perry, G. L., Zhu, X., Greco, S. J., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1021 · Cited by 127
Leptin Dysfunction and Alzheimer’s Disease: Evidence from Cellular, Animal, and Human Studies
McGuire, M. J., & Ishii, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0282-7 · Cited by 129
Mu, W., Cheng, X., Liu, Y., Lv, Q., Gao-lin, L., Zhang, J.-G., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01566 · Cited by 127
Leptin Impairs Insulin Signaling in Rat Adipocytes
Pérez, C., Fernández‐Galaz, C., Fernández‐Agulló, T., Arribas, C., Andrés, A., Ros, M., & Carrascosa, J. M. (2004) · Diabetes · doi:10.2337/diabetes.53.2.347 · Cited by 132
Chen, H. C., Smith, S. J., Tow, B., Elias, P. M., & Farese, R. V. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213880 · Cited by 123
GENETIC MODELS OF OBESITY AND ENERGY BALANCE IN THE MOUSE
Robinson, S. W., Dinulescu, D. M., & Cone, R. D. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.687 · Cited by 122
Kazumi, T., Kawaguchi, A., Hirano, T., & Yoshino, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.008 · Cited by 122
Simha, V., Szczepaniak, L. S., Wagner, A. J., DePaoli, A. M., & Garg, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.30 · Cited by 121
The role of leptin in diabetes: metabolic effects
Meek, T. H., & Morton, G. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3898-3 · Cited by 127
White adipose tissue and cardiovascular disease
Matsuzawa, Y. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.001 · Cited by 119
Adipose Tissue: Physiology to Metabolic Dysfunction
Richard, A. J., White, U. A., Elks, C. M., & Stephens, J. M. (2020) · Europe PMC (PubMed Central) · Cited by 118
Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins
You, M., & Crabb, D. W. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.07.004 · Cited by 119
Metadata
- Authors
- Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Brown, Michael S.
- Goldstein, Joseph L.
- Venue
- Nature
- Published
- 1999-09
- Volume
- 401
- Issue
- 6748
- Pages
- 73-76
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1492605893
- Cited by
- 1,038
- References
- 15
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 22 · 2023: 24 · 2022: 19 · 2021: 20 · 2020: 20 · 2019: 23 · 2018: 31 · 2017: 29 · 2016: 30 · 2015: 38 · 2014: 36 · 2013: 39 · 2012: 43
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- leptin, congenital generalized lipodystrophy, insulin resistance, diabetes mellitus, transgenic mouse model, adipose tissue, hyperinsulinemia, hyperglycemia, hepatic steatosis, glucose disposal, dietary restriction, energy metabolism
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Disease Models, Animal, DNA-Binding Proteins, Female, Food Deprivation, Humans, Insulin Resistance, Lipodystrophy, Liver, Male, Mice, Obese, Mice, Transgenic, Nuclear Proteins, Promoter Regions, Genetic, Proteins, Transcription Factors, Adipocytes, Leptin, CCAAT-Enhancer-Binding Proteins, Mice, Sterol Regulatory Element Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
